Will Genetic Testing Shape the Future of Patient Centric Treatments?
Across all therapeutic classes with CNS drugs being even less efficacious than other categories, roughly 85% of prescription medicines are found ineffective in 25% of the treatment population. The figures make a bleaker picture if full and complete dosage compliance is factored into these findings. Genetic profiling to ameliorate treatment plans for a patient is still a controversial issue amongst clinicians despite the initiative in recent years for treatment programs and drugs to be tailor made for specific groups and even individuals and hence soliciting a DNA profile to be taken. However, there are certain genetic tests which fail to elucidate all possible gene mutations that can lead to disease, or lack the predictive power to even make a diagnosis in some while the inborn errors from metabolism can also not be ruled out. One positive benefit has been seen in genetic screening of infants for phenylketonuria (PKU), then with dietary intervention allows the infant to grow into a h